Getty Images
The Institute for Cancer Research has announced a £75m investment.

New drugs that prevent cancer cells becoming resistant to treatment could be available within ten years.

The Institute for Cancer Research (ICR) has announced a £75m investment to develop new cancer managing drugs.

Whilst scientists continue to look for a cure, this programme aims to make cancer a manageable disease that people can live with. Patients could live a longer, better quality of life.

The £75m will fund a new Centre for Drug Discovery at the ICR’s Sutton campus. It will bring together 300 scientists to work on the cancer crackdown.

The first drug they develop will target a molecule called APOBEC. This could be available within the decade.

The ICR’s Dr Olivia Rossanese said: “We believe this will be the first treatment in the world that, rather than dealing with the consequences of cancer’s evolution and resistance, aims to directly confront the disease’s ability to adapt and evolve in the first place.”

“This Darwinian approach to drug discovery gives us the best chance yet of defeating cancer.”